These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36792306)

  • 1. Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts.
    Márquez DF; Rodríguez-Sánchez E; de la Morena JS; Ruilope LM; Ruiz-Hurtado G
    Nefrologia (Engl Ed); 2022; 42(5):519-530. PubMed ID: 36792306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension-Mediated Organ Damage and Long-term Cardiovascular Outcomes in Asian Hypertensive Patients without Prior Cardiovascular Disease.
    Oh JS; Lee CH; Park JI; Park HK; Hwang JK
    J Korean Med Sci; 2020 Dec; 35(48):e400. PubMed ID: 33316856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score.
    Rizzoni D; Agabiti-Rosei C; De Ciuceis C; Boari GEM
    High Blood Press Cardiovasc Prev; 2023 Jan; 30(1):17-27. PubMed ID: 36376777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population.
    Armas-Padrón AM; Sicilia-Sosvilla M; Ruiz-Esteban P; Torres A; Hernández D
    Nefrologia (Engl Ed); 2024; 44(1):77-89. PubMed ID: 37150674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of hypertension-mediated organ damage in children and adolescents with hypertension.
    Pac M; Obrycki Ł; Koziej J; Skoczyński K; Starnawska-Bojsza A; Litwin M
    Blood Press; 2023 Dec; 32(1):2212085. PubMed ID: 37259507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage.
    Brobak KM; Halvorsen LV; Aass HCD; Søraas CL; Aune A; Olsen E; Bergland OU; Rognstad S; Blom KB; Birkeland JAK; Høieggen A; Larstorp ACK; Solbu MD
    Blood Press; 2024 Dec; 33(1):2323980. PubMed ID: 38606688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between antecedent blood pressure, hypertension-mediated organ damage and cardiovascular outcome.
    Olesen TB; Pareek M; Stidsen JV; Blicher MK; Rasmussen S; Vishram-Nielsen JKK; Maagaard L; H Olsen M
    Blood Press; 2020 Aug; 29(4):232-240. PubMed ID: 32157916
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of hypertension and target organ damage in patients with 11β-hydroxylase deficiency.
    Sun B; Lu L; Gao Y; Yu B; Chen S; Tong A; Wu X; Mao J; Wang X; Zhao Z; Zhang W; Nie M
    Clin Endocrinol (Oxf); 2022 May; 96(5):657-665. PubMed ID: 35067946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients.
    Romero-Secin AA; Díez-Espino J; Prieto-Díaz MA; Pallares-Carratala V; Barquilla-García A; Micó-Pérez RM; Polo-García J; Velilla-Zancada SM; Martín-Sanchez V; Segura-Fragoso A; Ginel-Mendoza L; Arce-Vazquez VM; Cinza-Sanjurjo S
    Semergen; 2024 Mar; 50(6):102220. PubMed ID: 38554607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events.
    Lembo M; Pacella D; Manzi MV; Morisco C; La Mura L; Mancusi C; Bardi L; Trimarco V; Trimarco B; Izzo R; Esposito G
    Eur Heart J Open; 2023 Sep; 3(5):oead102. PubMed ID: 37881599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate Associations of 24-h Central Aortic and Brachial Cuff Blood Pressure With Hypertension-Mediated Organ Damage and Cardiovascular Risk.
    Hu Y; Zhao J; Wang Q; Chao H; Tang B; Cheng D; Tan I; Butlin M; Avolio A; Wang W; Zuo J
    Front Cardiovasc Med; 2022; 9():795509. PubMed ID: 35274011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.
    Miceli F; Presta V; Citoni B; Canichella F; Figliuzzi I; Ferrucci A; Volpe M; Tocci G
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1863-1871. PubMed ID: 31693279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization cardiovascular risk stratification and target organ damage.
    Piskorz D; Bongarzoni L; Citta L; Citta N; Citta P; Keller L; Mata L; Tommasi A
    Hipertens Riesgo Vasc; 2016; 33(1):14-20. PubMed ID: 26521088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why take organ damage in hypertension seriously?
    Kociánová E
    Vnitr Lek; 2022; 68(5):303-308. PubMed ID: 36283821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical HMOD in Hypertension: Brain Imaging and Cognitive Function.
    Scuteri A; Antonelli Incalzi R
    High Blood Press Cardiovasc Prev; 2022 Nov; 29(6):577-583. PubMed ID: 36404361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012-2015.
    Wang X; Hao G; Chen L; Yang Y; Zhou H; Kang Y; Shaver L; Chen Z; Zheng C; Zhang L; Li S; Wang Z; Gao R
    J Hum Hypertens; 2022 Dec; 36(12):1092-1098. PubMed ID: 34799686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Indices of Home Blood Pressure Variability and Hypertension-Mediated Organ Damage in Treated Hypertensive Patients.
    Barochiner J; Martínez R; Aparicio LS
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):365-372. PubMed ID: 33881750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of hypertension-mediated organ damage in a series of Chinese patients with 17α-hydroxylase deficiency.
    Zhao Z; Lu L; Wang O; Wu X; Sun B; Zhang W; Wang X; Mao J; Chen S; Tong A; Nie M
    Endocrine; 2022 Apr; 76(1):151-161. PubMed ID: 35032013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of ABPM and subclinical target organ damage parameters in diagnosis of resistant hypertension.
    Poveda García MI; Del Pino Y Pino MD; Alarcón Rodriguez R; Rodelo-Haad C; Parrón Carreño T
    Nefrologia (Engl Ed); 2019; 39(1):67-72. PubMed ID: 30001849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.